LivaNova's average Accounts Receivable for the
three
months ended in Dec. 2023 was $202 Mil. LivaNova's Revenue for the
three
months ended in Dec. 2023 was $310 Mil.
Hence, LivaNova's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 59.57.
The historical rank and industry rank for LivaNova's Days Sales Outstanding or its related term are showing as below:
LIVN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.9 Med: 65.49 Max: 89.31
Current: 60.26
During the past 13 years, LivaNova's highest Days Sales Outstanding was 89.31. The lowest was 49.90. And the median was 65.49.
LIVN's Days Sales Outstanding is ranked better than 54.28% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 63.94
vs LIVN: 60.26
LivaNova's Days Sales Outstanding
increased
from Dec. 2022 (58.96) to Dec. 2023 (59.57).
LivaNova Days Sales Outstanding Historical Data
The historical data trend for LivaNova's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LivaNova's Days Sales Outstanding
For the Medical Devices subindustry, LivaNova's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LivaNova's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where LivaNova's Days Sales Outstanding falls into.
LivaNova Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LivaNova (NAS:LIVN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
LivaNova Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of LivaNova's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LIVN has been successfully added to your 